- •Acknowledgment
- •Abbreviations and Glossary
- •Contents
- •Introduction
- •1: Should You Become a VR Surgeon?
- •2.2 A Word of Caution
- •Introduction
- •3: Fundamental Rules for the VR Surgeon
- •3.4 The “What, When, How – and Why” Questions
- •3.5 Don’t Start What You Cannot Finish
- •3.6 Common Sense vs Dogma
- •3.7 Maximal Concentration During the Entire Operation
- •3.8 Make Life as Easy for Yourself as Possible
- •3.9 Under Peer Pressure: To Yield or Not to Yield
- •3.10 Referral of the Patient
- •3.11 The Rest of the Eyeball…
- •4.1 What If the Surgeon Has Tremor?
- •4.2 How Important Is Good Dexterity?
- •4.5 Combined Surgery or Cataract Surgery Separately?
- •4.7 How Much Confidence in Himself Should the VR Surgeon Have?
- •4.8 How Long Do Vitrectomies Take?
- •4.9 Was Surgery Successful?
- •5.1 The “Target” of Counseling
- •5.2 The Patient Does Not Know Most of What Is so Obvious to the Surgeon
- •5.3 Communicating with the Patient
- •5.4 Coaching vs Trying to Be Objective
- •5.5 The Ultimate Treatment Decision: “Whose Eye Is It?”
- •5.6 Which of the Two Eyes to Operate on First?
- •5.7 What if the Eye Has Two Diseases?
- •5.8 What if the Eye Has Severe Visual Loss and the Chance of Improvement with Another Surgery Is Low?
- •5.9 Empathy: The Single Most Important Component of Counseling
- •5.10 The Prognosis with the Chosen Surgical Option
- •5.11 If the Patient Chooses to Undergo Surgery
- •5.12 The Benefits of Proper Counseling
- •5.14 The Dogmas
- •6: The VR Surgeon’s Relation to His Nurse
- •7: Examination
- •8: The Indication Whether to Operate
- •8.1 The Argument in Favor of Surgery
- •8.3 The Age of the Patient
- •8.4 The Condition of the Fellow Eye
- •11: The Surgeon’s Relation to Himself
- •11.3 Self-Examination
- •Introduction
- •12.1.1 The Pump
- •12.1.1.1 Peristaltic Pump: Flow Control
- •12.1.2 The Probe
- •12.1.2.2 Port Location
- •12.1.2.3 Port Configuration and Size
- •12.1.2.4 Cut Rate
- •12.1.2.6 Probe Length
- •12.1.3 The Light Source/Pipe
- •12.1.4 The Infusion Supply
- •12.1.5 The Trocar
- •12.1.6 The Cannula
- •12.1.7 System to Inject/Extract Viscous Fluid
- •12.1.8 The Pedal
- •12.1.10 Endodiathermy Probe
- •12.1.11 The User Interface of the Vitrectomy Console
- •12.1.12 Troubleshooting
- •12.2 The Microscope
- •13: Instruments, Tools, and Their Use
- •13.2.1.1 General Concepts of Working with Squeezable Instruments
- •13.2.1.2 The Handle
- •13.2.1.3 Forceps
- •13.2.1.4 Scissors
- •13.2.2 Hybrid Instruments
- •13.2.2.2 Retractable Instruments
- •13.2.3 Non-squeezable Hand Instruments
- •13.2.3.1 Bent (Hooked, Barbed) Needle
- •13.2.3.2 Membrane Scraper
- •13.2.3.3 Spatula/Pic
- •13.2.3.4 Intraocular Magnet
- •13.3.1 Membrane Dissection (“Viscosurgery”): Viscoelastics as a Spatula
- •13.3.2 Opening a Closed Funnel
- •14: Materials and Their Use
- •14.2 Intravitreal Gas
- •14.3 Silicone Oil
- •14.3.1 Types of Silicone Oil
- •14.3.3 Complications Related to Silicone Oil Use
- •14.3.4 Complications Related to Silicone Oil Use Removal
- •14.4 PFCL
- •14.6 Sutures
- •15: Anesthesia
- •15.1 How to Decide the Type of Anesthesia
- •15.2 If Local Anesthesia Is Chosen
- •15.3 Medications If Local Anesthesia Is Used
- •16: The Surgeon at the Operating Table
- •16.1 The OR Personnel
- •16.2 The Operating Table and the Surgeon’s Chair
- •16.2.1 The Operating Table
- •16.2.2 The Surgeon’s Chair
- •16.4 The Microscope
- •16.5 The BIOM
- •16.5.1 BIOM: The Advantages
- •16.5.2 BIOM Use: Practical Information
- •16.5.3 BIOM: Setting Up for Daily Use
- •16.5.4 BIOM: Checklist
- •16.5.5 BIOM: Troubleshooting
- •16.6 The Patient
- •16.7 The Surgeon
- •16.7.2 At the Start of Vitrectomy
- •16.7.3 Staring into the Microscope
- •16.8 Music in the OR
- •16.9 The Brightness in the OR
- •16.10 The Quality of the Air in the OR
- •16.12 The Blueprint of the OR
- •16.13 The Captain in the OR
- •16.14 The Fundamental Technical Rules of Performing Intravitreal Surgery
- •Introduction
- •17.3 The Endoscope Approach (EAV)
- •17.4 Portable Systems
- •17.5 3D Viewing
- •18.1 Disinfection and Draping
- •18.2 The Monocular Patient
- •18.3 At the Conclusion of the Operation
- •19: The Speculum and Its Placement
- •19.1 General Considerations
- •19.2 Speculum Placement
- •20.3 Injecting into the Vitreous Cavity During Surgery
- •21: Sclerotomies and the Cannulas
- •21.2 Location of the Sclerotomies
- •21.2.1 Distance from the Limbus
- •21.2.2 Location in Clock Hours
- •21.2.3 In Case of a Reoperation
- •21.2.4 In Case of Scleral Thinning
- •21.3 Inserting the Cannula
- •21.4 The Order of Cannula Placement
- •21.5 If the Palpebral Opening Is Small
- •21.6 Checking the (Infusion) Cannula
- •21.6.1 Cannula Under the Choroid/Retina: Prevention
- •21.6.2 Cannula Under the Choroid/Retina: Management
- •21.6.3 Infusion Going Under the Choroid/Retina: Management
- •21.7 The Cannulas in Use
- •21.8 The Removal of the Cannulas
- •21.8.1 Hypotony: The Causes
- •21.8.2 Hypotony: The Consequences
- •21.8.3 Hypotony: Prevention
- •21.8.4 Hypotony: Postoperative Management
- •22: Illumination
- •22.1 The Light Pipe
- •22.3 Light Built into the Handheld Instruments
- •24: Using the Vitrectomy Probe
- •24.1 Removal of the Vitreous
- •24.2 Removal of Proliferative Membranes
- •24.3 Removal of the Retina
- •24.4 Removal of the Lens
- •25: Maintaining Good Visualization
- •25.1.1 The Microscope
- •25.1.2 The Contact Lens
- •25.1.3 The Corneal Surface
- •25.1.4 The Corneal Stroma
- •25.2 Internal Factors
- •25.2.2 Pupil
- •25.2.2.1 Mechanical Forces Preventing Pupil Dilation
- •25.2.2.2 Intracameral Adrenalin or Visco
- •25.2.2.4 Iris Ring
- •25.2.2.5 Iridotomy
- •25.2.3 Lens
- •25.2.3.1 Cataract
- •25.2.3.2 “Feathering”
- •25.2.3.3 “Gas Cataract”
- •25.2.3.4 “Lens Touch”
- •25.2.4.1 Phimosis of the Anterior Capsule
- •25.2.4.2 Deposit on the Anterior IOL Surface
- •25.2.4.3 Problems with the IOL Itself
- •25.2.4.4 Fluid Condensation
- •25.2.5 The Posterior Capsule
- •25.2.6 The Vitreous Cavity
- •25.2.7 Epiretinal (Subhyaloidal) Materials
- •25.2.7.1 Blood
- •25.2.8 The Surgeon’s Actions
- •25.2.9 “Chromovitrectomy”
- •26.1.1 Vitreous Macroanatomy
- •26.1.2 Vitreous Biochemistry and Its Anatomical and Functional Implications
- •26.1.3 Retinal Histology and Macroanatomy
- •26.1.4 Anterior Segment Dimensions
- •26.2 External Anatomy for the VR Surgeon
- •26.3 Physiology: What Keeps the Retina Attached?
- •26.3.1 The RPE Pump
- •26.3.3 Presence of the Vitreous Gel
- •27: The Basics of Vitreous Removal
- •27.1 The Rationale for PPV
- •27.2 How Much Vitreous to Remove?
- •27.3 Recognizing the Presence of the Vitreous Gel
- •27.3.1 Mechanical Aids
- •27.3.2 Air (Pneumovitrectomy)
- •27.3.3 Stains and Markers
- •27.4 The Sequence of Vitreous Removal
- •27.5.2 Vitrectomy Anterior to the Equator
- •27.5.3 Vitrectomy Behind the Lens
- •28: Scleral Indentation
- •28.1 The Advantages of Scleral Indentation
- •28.2 The Mechanics of Vitrectomy with Scleral Indentation
- •28.3 Internal vs External Illumination
- •28.5 External Illumination and Nurse Indentation
- •28.6 Instrumentation and Technique
- •29: Cryopexy
- •29.1 Indication in RD
- •29.2 Surgical Technique
- •29.3 Cryopexy as a Destructive Force
- •30: Endolaser
- •30.1 The Consequences of Laser Treatment
- •30.2 The Setup
- •30.3 The Technique of Endolaser Treatment
- •30.3.1 General Considerations
- •30.3.2 Panretinal Treatment
- •30.3.3 Endolaser Cerclage and Its Complications
- •30.3.4 Endolaser as a Walling-Off (Barricading) Tool
- •30.3.5 Endolaser as a Welding Tool
- •30.4 Peripheral Laser and the Beginner VR Surgeon
- •30.5 Endocyclophotocoagulation
- •30.6 Laser Cerclage at the Slit Lamp
- •31: Working With and Under Air
- •31.1.1 Attached Retina
- •31.3 The Utilization of an Air Bubble
- •32: Working with Membranes
- •32.1.1 Instrumentation and Infrastructure
- •32.1.2 Opening the ILM
- •32.1.2.1 Sharp Opening: Incision First
- •32.1.2.2 Blunt Opening: No Incision
- •The Scraper
- •32.1.3 Peeling the Membrane
- •32.1.4 The Extent of ILM Peeling
- •32.1.5 What If the ILM Cannot Be Peeled?
- •32.1.6 ILM Removal in Eyes with Detached Macula
- •32.1.6.1 Reattaching the Macula First
- •32.1.6.2 Peeling When the Macula Is Still Detached
- •32.2.2 Removal Technique
- •32.2.2.1 Staining or Not?
- •32.2.2.2 Instrumentation
- •32.2.2.3 Location of the Point of Attack
- •32.2.2.4 The Major Risks When First Grabbing an EMP
- •32.2.2.5 The Direction of Peeling: Centripetal vs Centrifugal
- •32.2.2.6 The Speed of Peeling
- •32.2.2.7 The Extent of Peeling
- •32.2.2.8 ILM Peeling
- •32.2.2.9 Completion of Surgery
- •32.3.1.1 Recognition
- •32.3.1.2 The Goals of Surgery
- •32.3.1.3 Instrumentation
- •32.3.1.4 Surgical Steps
- •32.3.1.5 Closed Funnel/Retinal Incarceration
- •32.3.1.6 ILM Removal
- •32.4 Subretinal Membranes/Strands
- •33.1 Retinectomy
- •34: Chromovitrectomy
- •34.1 Posterior Vitreous Cortex
- •34.3.1 False-Positive Staining with ICG
- •34.3.2 Injection Technique for Staining the ILM
- •34.4 Newly Formed (PVR) Membranes
- •35: Tamponades
- •35.2 Gases
- •35.2.1 General Considerations
- •35.2.3 Gas Injection into the Nonvitrectomized Eye
- •35.2.4 The Eye with Gaseous Tamponade
- •35.3.1 Indications to Use Heavier-Than-Water Liquids
- •35.3.2 Surgical Technique
- •35.3.2.1 Implantation
- •35.4 Silicone Oil
- •35.4.1 Selecting the Type of Silicone Oil to Implant
- •35.4.2 General Considerations
- •35.4.3 Indications
- •35.4.3.1 Semipermanent Tamponade
- •35.4.3.2 Permanent Tamponade
- •35.4.4 Implantation
- •35.4.5 With Silicone Oil in the Eye
- •35.4.5.1 General Considerations
- •35.4.5.2 Emulsification
- •35.4.6 Removal
- •35.4.6.1 Timing
- •35.4.6.2 Surgical Technique
- •35.5 Exchanges
- •35.6 If the Eye Is Aphakic
- •36: Submacular Hemorrhage
- •36.1 The Nonsurgical Approach: Intravitreal Gas and tPA
- •36.2 Removal of the Clot In Toto
- •36.4 The Minimalistic Surgical Approach
- •37: Subretinal Biopsy
- •38: Combined Surgery
- •38.1 Phacoemulsification
- •38.2 Lensectomy
- •38.2.1 Lens In Situ
- •38.3.1 Lens In Situ
- •38.3.2 Lens in Vitreous
- •38.4.2 No IOL Implantation
- •38.5 Capsule Removal
- •38.5.1 Indications
- •38.5.2 Surgical Technique
- •38.6.1 Advantages
- •38.6.2 Surgical Technique
- •38.6.3 Subsequent Sub/luxation of an Iris-Claw IOL
- •38.6.3.1 Subluxated Lens
- •38.6.3.2 Luxated Lens
- •39: AC Basics
- •39.1 Paracentesis
- •39.2 Iris Prolapse
- •39.3 Anterior Synechia
- •39.5 Material in the AC
- •40.2 Retinal Tear
- •40.3 Reopening of a Posterior Scleral Wound
- •40.4 Lens/IOL Trauma
- •41: Pediatric Patients
- •42: The Highly Myopic Eye
- •42.1 The Risk of RD If Cataract Surgery Is Needed
- •42.2 Vitrectomy in the Highly Myopic Eye
- •42.3 Posterior RD over a Staphyloma
- •43: Intravitreal Injections
- •Introduction
- •44: Dropped Nucleus and Dislocated IOL
- •44.1 General Considerations
- •44.1.2 Dislocated IOL
- •44.2 Surgical Technique
- •44.2.1 Dropped Nucleus
- •45: Endophthalmitis
- •45.1 General Considerations
- •45.1.1 Etiology
- •45.1.2 Clinical Diagnosis
- •45.1.3 Timing
- •45.1.4 Treatment Options and Management Philosophy
- •45.2 Surgical Technique
- •45.3 Posttraumatic Endophthalmitis
- •46: Floaters
- •46.1 General Considerations
- •46.1.1 Indication for Surgery
- •46.1.2 Timing of Surgery
- •46.2 Surgical Technique
- •47: Hyphema
- •47.1 General Considerations
- •47.1.1 The Rationale for Surgical Removal
- •47.1.2 Medical Treatment
- •47.2 Surgical Technique
- •47.2.1 Liquid Blood
- •47.2.1.1 Monomanual Technique
- •47.2.1.2 Bimanual Technique
- •47.2.2 Clotted Blood
- •48: Iris Abnormalities
- •48.1 General Considerations
- •48.1.2 Timing of Iris Reconstruction
- •48.2 Surgical Technique
- •48.2.2 Iridodialysis
- •48.2.3 Permanent Mydriasis
- •49: Macular Disorders: Edema
- •49.1 General Considerations
- •49.1.1 Etiology
- •49.1.2 Indications for Treatment: Surgical or Nonsurgical?
- •50.1 General Considerations
- •50.1.1 VMTS
- •50.1.2 Cellophane Maculopathy
- •50.1.3 Macular Pucker
- •50.1.4 Macular Hole
- •50.2.1 VMTS
- •50.2.2 Cellophane Maculopathy
- •50.2.3 Macular Pucker
- •50.2.4 Macular Hole
- •50.2.5 If Surgery Failed for a Macular Hole
- •51: Optic Pit
- •51.1 General Considerations
- •51.2 Surgical Technique
- •52.1 General Considerations
- •52.1.1 Indications
- •52.1.2 Preoperative Considerations
- •52.2 Surgical Technique
- •53.1 General Considerations
- •53.2 Surgical Technique
- •54: Retinal Detachment
- •54.1.1 RD Due to a Horseshoe or Giant Tear
- •54.1.2 RD Due to a Dialysis
- •54.1.3 RD Due to a Round Hole
- •54.1.4 RD Due to a Staphyloma
- •54.2 Additional Information About RD
- •54.2.1 History
- •54.2.3 Clinical Course
- •54.2.4 Using Laser to Prevent RD Development
- •54.2.4.1 Prophylaxis in the Affected Eye (RD, Current or Past)
- •54.2.4.2 Prophylaxis in the Fellow Eye
- •54.2.4.3 The Patient with a History of a Retinal Tear (No RD)
- •54.3 Treatment Principles
- •54.3.2 The Goals of Surgery
- •54.3.3 Prognosis
- •54.4.1 Preoperatively
- •54.4.2.1 Initial Steps
- •54.4.2.2 Creating a Chorioretinal Adhesion
- •54.4.2.3 Drainage of the Subretinal Fluid
- •54.4.2.5 Suturing
- •54.4.2.7 Adjusting the Buckle
- •54.4.2.8 Closing the Conjunctiva
- •54.4.2.9 Gas Tamponade
- •54.4.3 Major Intraoperative Complications of SB
- •54.5 Vitrectomy
- •54.5.2.3 Intraoperative Retinal Reattachment
- •54.5.2.4 Laser Retinopexy
- •54.5.2.5 Intraocular Tamponade
- •54.5.2.6 Postoperative Positioning
- •54.5.3 Follow-Up Visits
- •54.5.4 Prognosis
- •54.5.5 RD After Silicone Oil Removal
- •54.6 Pneumatic Retinopexy
- •54.6.1 General Considerations
- •54.6.2 Patient Selection
- •54.6.3 Surgical Options
- •54.6.3.1 Cryopexy, Followed by Gas Injection
- •54.6.3.2 Gas Injection, Followed by Laser
- •54.7 Reoperation
- •55: RD, Tractional and Combined
- •55.1.1 Characteristics of the RD
- •55.1.2 Management Principles
- •56: RD, Central
- •56.1 General Considerations
- •56.2 Surgical Technique
- •57: Retinoschisis
- •57.1.1 Anatomy and Pathophysiology
- •57.1.2 Prophylactic Laser Treatment
- •57.2 Surgical Technique
- •58.1 General Considerations
- •58.1.1 Treatment Options
- •58.1.2 The Vitrectomy Option
- •58.2 Surgical Technique
- •59: Scleroplasty
- •59.1 General Considerations
- •59.2 Surgical Technique
- •60: Suprachoroidal Hemorrhage
- •60.1.1 Indications for Surgery
- •60.1.2 Timing of Surgery
- •60.2 Surgical Technique
- •61: Uveitis, Posterior
- •62: Vitreous Hemorrhage
- •62.1 General Considerations
- •62.2 Surgical Technique
- •62.3 Severe Bleeding in a Young Patient
- •62.4 Rebleeding in a Vitrectomized Eye
- •63: Trauma
- •63.1 The Timing of Surgery
- •63.2 Contusion
- •63.3 Wound Toilette
- •63.5 Suturing the Sclera
- •63.6 Subluxated Lens
- •63.7 IOFB
- •63.7.2 Posterior Segment
- •63.8 Perforating Trauma and Ruptures
- •63.9 NLP and Sympathetic Ophthalmia
- •63.11 Hemorrhagic RD
- •63.12 Additional Considerations
- •64: Postoperative Care
- •Further Reading
- •Appendix
- •Part 2. Important Personal Experiences
14.4 PFCL |
123 |
|
|
contact is not intermittent but permanent and the entire surface of the endothelium is involved), the development of band keratopathy is markedly delayed. This is why a phthisical eye needs to be made aphakic with a 100% oil fill,23 preferably with 5,000 cst oil (deferring emulsification, see above).
14.3.4 Complications Related to Silicone Oil Use Removal
•Oil sticking to the retina if during the original surgery PFCL was directly exchanged with heavy oil: an easily avoidable problem.24
•RD, occurring in up to a fifth of the cases (see Sect. 35.4.6).25
•VA loss upon silicone oil removal: a fortunately rare occurrence. Why vision drops after oil extraction and does not recover remains a mystery.
14.4PFCL
Unlike the true tamponades, the heavy fluid is an intraoperative tool, not intended to be retained after PPV. It is an extremely useful “third hand” in many situations, but it should not be overused (see Table 14.4).
Complications:
•PFCL has a high tendency to evaporate.
–The nurse should not keep it in an open container or it will rapidly disappear “into thin air.”
–This evaporation is the reason why, upon intraocular injection, it is virtually impossible to avoid implanting a small air bubble into the vitreous, even if the nurse carefully pushed all the air out of the cannula.26 This bubble is usually stuck to the anterior (i.e., superior) surface of the enlarging PFCL bubble and remains centrally located (see Fig. 33.1).
–In the air-filled eye, the evaporation continues: small bubbles gather on the back surface of the posterior capsule/IOL. This interferes with visualization (the bubbles can easily be aspirated but will reaccumulate if the air is not replaced with fluid) and causes loss of PFCL in the back where it would be needed.
•A PFCL bubble inadvertently left in the subretinal space is potentially toxic. Unless it is under the fovea, however, it is not justified to perform surgery just to remove the bubble.
23The oil is in permanent contact with the endothelium, making it impossible for the little remaining aqueous to enter the corneal stroma. Even then, corneal complications are inevitable.
24A hyperviscous solution that makes subsequent silicone oil removal very difficult. It is best to prevent this by exchanging the PFCL to air first, not directly to heavy oil.
25The figure depends on many factors such as the original indication, the type and quality of the original and subsequent surgeries, and intraocular events since the last operation.
26Caused by the evaporation of the PFCL from the inside of the cannula used for the injection.
124 |
|
14 Materials and Their Use |
|
||
Table 14.4 Examining the routine use of PFCL in various conditions* |
||
|
Routine PFCL |
|
Condition |
use justified? |
Reasoning |
Giant tear-related RD, especially |
Yes |
It is possible, but very difficult, to flip the |
if the retina is flipped over |
|
retina back if heavy fluid is unavailable |
Stabilizing a mobile or completely |
Yes |
Without PFCL there is a high risk of the |
detached retina |
|
probe biting into the retina, especially |
|
|
toward/at the periphery but even |
|
|
centrally |
Control of acute intraocular |
Yes |
It tamponades the bleeding and does not |
bleeding |
|
mix with the blood |
Expulsion of liquefied |
Yes |
It helps in pushing the blood anteriorly and |
suprachoroidal blood |
|
toward the sclerotomy (i.e., externally) |
Full opening of a closed |
No/yes |
No if the circumferentially cut and |
funnel/360° retinectomy |
|
collapsed retina is supposed to be |
performed |
|
opened/unfolded by PFCL |
|
|
Yes if PFCL is injected after the funnel’s |
|
|
partial opening by viscoelastics and the |
|
|
removal of traction forces |
Extensive subretinal |
Yesa |
Easy access to the subretinal space/retinal |
manipulations are required |
|
back surface is created, but all the |
and the retina is difficult to |
|
PFCL must meticulously be removed |
keep away |
|
once the subretinal work has been |
|
|
completed |
Relaxing retinotomy/<360° |
Yes/no |
Yes only if the retina does not reattach |
retinectomy |
|
under air |
Central RD where ILM peeling is |
Yes/no |
Yes since the PFCL reattaches the retina, |
plannedb |
(judgment |
even if it does not prevent movement of |
|
call) |
the retina under the bubble (see Sect. |
|
|
32.1.6.1) |
|
|
No since with a special ILM-peeling |
|
|
technique, there is no need for PFCL |
|
|
use (see Sect. 32.1.6.2) |
Bringing to the surface a dropped |
Yes/no |
Yes if the lens is so hard that |
nucleus |
|
phacofragmentation would threaten |
|
|
with corneal/retinal damage |
|
|
No in all other conditionsc |
Nonmetallic IOFBs |
Yes/no |
Yes if the IOFB is very large or has a |
|
|
shape/surface that makes it impossible |
|
|
to safely grab it with forceps |
|
|
No in all other cases: expensive and |
|
|
unnecessary |
Metallic IOFBs |
No |
The permanent intraocular magnet is the |
|
|
right tool. In addition, there is always a |
|
|
possibility that the PFCL will cover the |
|
|
IOFB, rather than lift it up |
Bringing to the surface a dropped |
No |
The haptic of the IOL is easy to grab with |
IOL |
|
forceps (see Sect. 44.2.2) |
Expulsion of still-clotted |
No |
It does not work |
suprachoroidal blood |
|
|
|
|
(continued) |
14.5 Viscoelastics |
|
125 |
|
|
|
Table 14.4 (continued) |
|
|
|
Routine PFCL |
|
Condition |
use justified? |
Reasoning |
“Normal” (“average”) RD |
No |
Expensive and unnecessary. There is also |
|
|
the risk of leaving small PFCL bubbles |
|
|
behindd. PFCL should be used only |
|
|
when the retinal break is too peripheral |
|
|
to allow complete draining of the |
|
|
subretinal fluid |
TRD/PVR |
No |
Elimination of the traction forces is the key |
TRD/PDR |
No |
to success, which does not require |
|
|
routine PFCL use. PFCL is used only |
|
|
when all traction is relieved and the |
|
|
retina will still not reattach with air or |
|
|
there is a retinal break too peripheral to |
|
|
drain through |
*Defined here as PFCL used not because the condition of the eye demands it but because of peer pressure or because of a surgeon who does not consciously weigh the benefits/downsides of PFCL use in each case.
aThe PFCL is injected into the subretinal space (i.e., behind the retina). bSee Chap. 56.
cThe smaller the PFCL bubble, the more it resembles a real sphere; with a partial fill, the lens particles tend to slide toward the bubble’s equator, i.e., close to the retina. To keep the particles centrally, either viscoelastic needs to be injected in a ring form or the entire vitreous cavity filled with PFCL.
dIt is not so uncommon to find, during reoperation following surgery done by a less experienced surgeon, large intravitreal PCFL bubbles or smaller ones in the AC or subretinally.
Q&A
Q Must you use a 2-way cannula (Chang) for PFCL injection?
ANo. Even the valved cannulas used in MISC usually leak enough to let the excess BSS/air out. The surgeon must monitor the optic disc during PFCL injection, and if it starts to turn pale must stop the injection and drain the BSS/air before continuing with the injection. The major downside of these exchanges is the repeated reimplantation of that ubiquitous air bubble.
14.5Viscoelastics27
These materials can be used, among others, for the following purposes:
•Create space: separation of two tissues (see Sect. 13.3.1) or deepening an existing space between them (see Sect. 32.3.1.5).
•Maintain space: keep the retinal funnel open or the AC deep.
27 Let me avoid the use of the term “ophthalmic viscosurgical device.” I prefer calling the automotive device with 4 wheels: a car. See Sect. 13.3 for additional details on visco use.
126 |
14 Materials and Their Use |
|
|
Fig. 14.5 Use of viscoelastics to press the silicone oil out of the AC. The cannula is entered into the AC through a paracentesis on the temporal side, then advanced to the furthermost point of the chamber. The visco is slowly injected while the lower lip of the wound is pressed downwards. The cannula is held perpendicular to the paracentesis incision so that the force of the visco has an equal effect on both sides (in fact, 360°). (If the cannula is obliquely held, more oil will be left behind on the side of the larger angle, and eventually an oil bubble will break off, requiring additional maneuvers to press out.) The visco pushes the oil in the opposite direction of its own flow and the oil readily escapes through the gaping wound (see also Fig. 35.3)
•Stop or isolate a fresh bleeding.
•Direct/channel fluid flow: raise the IOP by reducing aqueous outflow or force silicone oil out of the AC (see Fig. 14.5).
•Block/prevent fluid flow: prevent silicone oil from entering the AC or aqueous escaping through a wound.
•Block/prevent tissue movement: iris prolapse into a traumatic wound or paracentesis.
•Prevent water condensation on a surface (see Sect. 25.2.3.4).28
•Mechanical protection: a plug in the macular hole to prevent dye entry or when a sharp epiretinal IOFB must be grabbed by forceps.
14.6Sutures
A few of the most basic guidelines are presented here regarding needles, sutures, and their employment by the surgeon.
•Never grab needles at their tip.
–One common error is to have the needle cut too long a path, making it difficult to avoid grabbing the needle’s tip at the exit point.
28 For this purpose, it is the “viscous,” not the “elastic” component of the material that is utilized.
14.6 Sutures |
127 |
|
|
•The channel (suture track) created by the needle is always larger than the suture material that occupies the channel.
–Intraoperative leakage along the track in case of a 100% deep corneal suture (see Fig. 63.2b) is therefore unavoidable, but this ceases as the tissue swelling compresses the channel.
•Do not grab the cornea when suturing it (see Table 63.3).
–It is unnecessary because the needle is sharp enough to enter, pass through, and exit the tissue: it will not push the tissue away.29
•All sutures work by tissue compression. In most tissues, there is no untoward consequence of too much compression.
–In the cornea, too much compression results in tissue deformation, which distorts the view for both patient and ophthalmologist.
•In the cornea, all suture knots must be buried.
–Too large a knot makes it impossible to pull the knot into the suture channel.
–The suture should be cut short.
Pearl
A blade is preferred over scissors to cut the thread (Fig. 14.6). This gives the surgeon more control by increasing the visibility (the scissors may block the view) and precision (the suture is moved to the blade, not the other way around).
Even if the VR surgeon never in his life needs to place corneal sutures,30 closing scleral wounds will surely be necessary in MIVS or trauma (see Sects. 21.8.3 and 63.5).
Q&A
Q When do you have to close the sclerotomy in MIVS?
AThe default option is not to use sutures – this is what makes small-gauge PPV more comfortable for the patient than the traditional 20 g option. However, if the wound is leaking or silicone oil is used, it is advisable to suture-close it to avoid postoperative hypotony or subconjunctival displacement of the oil.
To close a sclerotomy, typically 7/0 vicryl (or silk) is used. The former is absorbable31; the latter is not, which is a strong argument in favor of the former.
29In all other tissues, the resistance against the advancing needle is high so the tissue tends to move with the needle in the same direction. The forceps is employed to counteract this movement: the surgeon pulls the tissue against the movement of the needle.
30Which is indeed difficult to imagine.
31I.e., the vicryl suture does not require removal, irrespective of whether it is in the conjunctiva or sclera.
128 |
14 Materials and Their Use |
|
|
Fig. 14.6 Cutting the suture thread short with a blade. (a) Suture in place and knot complete. (b) One
of the threads is grasped with forceps (F) and the blade (BL) positioned at the desired location (where the suture will be severed). The thread is pulled upwards and away from the blade (arrows).
(c) While continuing to pull the thread upwards, it is moved toward, and onto, the blade. The blade is then slightly moved against the thread, which is stretched so that it does not get pushed away by the blade (these movements are not shown for simplicity). (d) The result is a cut that is short enough to allow the knot to easily slide into the suture channel but not too short to threaten
with getting untied. The second thread has not been severed yet
a
F
b
BL
c
d
14.6 Sutures |
129 |
|
|
The difficulty of closure comes from the fact that many times neither the conjunctival nor the scleral wound is visible.
•If silicone oil has been used:
–The surgeon grabs, with his nondominant hand, the sclera with teeth forceps,32 and lifts the sclera slightly up.
–The surgeon removes the cannula with his other hand.
–The nurse places the needle holder into the surgeon’s outreached palm, making sure that the needle is facing the correct direction (away from or toward the surgeon, see Fig. 54.7).33 Meanwhile the surgeon keeps the wound lips pressed together with his nondominant hand.
–A double loop is created so that the incision is instantly closed when the suture itself is pulled up (Fig. 14.3).
If the scleral wound is not visible because of bleeding or chemosis, the conjunctiva may have to be incised.
32A colibri-type forceps with small teeth is the most optimal option.
33Another example of why a good nurse is so important.
- #28.03.202639.38 Mб0The Wills eye manual office and emergency room diagnosis and treatment of eye disease Adam T. Gerstenblith, Michael P. Rabinowitz.chm
- #
- #
- #
- #
- #
- #
- #28.03.202614.01 Кб0[Офтальмология] Jack J. Kanski Джек Дж. Кански - Клиническая офтальмология систематизированный подход [2006, PDF DjVu, RUS] [rutracker-5395873].torrent
- #
- #
- #
